AD Clinical Trial
Official title:
Development of a Diagnostic Tool for Alzheimer's Disease
The objective of this study is to compare the electroencephalography (EEG) responses of three distinct groups of individuals to scopolamine: 1) a group of Alzheimer Dementia (AD) patients, 2) a group of individuals suffering from Mild Cognitive Impairment (MCI) and 3) a group of controls. The main purpose of this comparison is to discover ways to use these responses to distinguish between the group of AD patients and controls in order to develop a diagnostic tool for AD. The purpose of including the MCI group is to investigate whether this diagnostic tool can predict which member of the MCI group will develop AD later in life.
n/a
Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04520308 -
An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
|
Phase 4 | |
| Recruiting |
NCT06155201 -
Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders
|
N/A | |
| Recruiting |
NCT06335836 -
The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
|
||
| Active, not recruiting |
NCT02380573 -
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
|
Phase 2 | |
| Terminated |
NCT01733355 -
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
|
Phase 0 | |
| Completed |
NCT03932916 -
Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01190904 -
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
|
N/A | |
| Recruiting |
NCT05372458 -
The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's Disease
|
||
| Enrolling by invitation |
NCT06245031 -
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
|
N/A | |
| Active, not recruiting |
NCT05984784 -
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
|
Phase 1/Phase 2 |